HomeInsights52 Week Low Stocks

Sun Pharmaceuticals Industries Ltd 52 Week Low

Sun Pharmaceuticals Industries Ltd 52 Week Low

stocks purchased

₹ 1.7 Cr

Volume transacted

stocks purchased

9.2 K

stocks traded

Last Updated time: 02 Nov 15:30 PM

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

YEARLOW

1082.8

Last updated on: Nov 01, 2024

Key Highlights

  • The 52 Week Low of Sun Pharmaceuticals Industries Ltd is ₹ 1082 as of 01 Nov 24.

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
01 Nov 20241858.7
31 Oct 20241849.05
30 Oct 20241852.45
29 Oct 20241870.9
28 Oct 20241902.65
25 Oct 20241860.25
24 Oct 20241849.05
23 Oct 20241838.1
22 Oct 20241886.65
21 Oct 20241896.45

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharmaceuticals Industries Ltd up for third straight session

Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...

Read more

28 Oct 202413:05

News

Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr

Profit before tax was at Rs 3,597.88 crore in Q2 FY25, registering a growth of 28.91% on Y...

Read more

28 Oct 202416:01

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

09 Oct 202417:30

News

Sun Pharma inks global licensing agreement with Philogen

Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...

Read more

01 Oct 202410:34

News

Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun

Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...

Read more

01 Oct 202410:34

News

Sun Pharma, Moebius Medical gets USFDA FTD to MM-II

MM-II is a novel non-opioid product that uses a proprietary suspension of large, empty, mu...

Read more

06 Sep 202412:55

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Sun Pharmaceuticals Industries Ltd

Why is it important to track the 52-week low of Sun Pharmaceuticals Industries Ltd stocks?

Investors should monitor the 52-week low of Sun Pharmaceuticals Industries Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Sun Pharmaceuticals Industries Ltd stocks hitting a 52-week low?

Factors leading to Sun Pharmaceuticals Industries Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Sun Pharmaceuticals Industries Ltd stocks when they hit a 52-week low?

Buying Sun Pharmaceuticals Industries Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Sun Pharmaceuticals Industries Ltd stocks?

Investors should monitor the 52-week low of Sun Pharmaceuticals Industries Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Sun Pharmaceuticals Industries Ltd stock at their 52-week low?

An investor can analyze the reasons for the Sun Pharmaceuticals Industries Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Sun Pharmaceuticals Industries Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Sun Pharmaceuticals Industries Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Sun Pharmaceuticals Industries Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*